0001225208-20-003782.txt : 20200228
0001225208-20-003782.hdr.sgml : 20200228
20200228191551
ACCESSION NUMBER: 0001225208-20-003782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200226
FILED AS OF DATE: 20200228
DATE AS OF CHANGE: 20200228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANGIALOSI LORETTA V
CENTRAL INDEX KEY: 0001174449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 20673573
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND ST.
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2020-02-26
0000078003
PFIZER INC
PFE
0001174449
CANGIALOSI LORETTA V
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Sr. Vice President, Controller
Common Stock
2020-02-26
4
M
0
24155.0000
34.5900
A
131196.0000
D
Common Stock
2020-02-26
4
A
0
3797.0000
0.0000
A
134993.0000
D
Common Stock
2020-02-26
4
F
0
1290.0000
34.7200
D
133703.0000
D
Common Stock
2020-02-26
4
F
0
1943.0000
34.7200
D
131760.0000
D
Common Stock
2020-02-26
4
F
0
18438.0000
36.8000
D
113322.0000
D
Common Stock
2666.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
34.5900
2020-02-26
4
M
0
24155.0000
0.0000
D
2020-02-26
2020-02-26
Common Stock
24155.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
Susan E. Grant, by power of atty., for Loretta V. Cangialosi
2020-02-28